510(k) device
Hairmax Lasercomb
Lexington International, LLC · Laser, Comb, Hair (OAP, Class II) · First FDA decision Jan 18, 2007, newest Sep 26, 2011Hair loss
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
5
510(k) pathway
Device trials
6
Naming "Hairmax Lasercomb"
MAUDE reports
0
Brand "Hairmax Lasercomb", since 2015
PubMed studies
8
Mentioning "Hairmax Lasercomb"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Hairmax Lasercomb
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology, with pictures of the device
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 5 of 5 decisions filed under this name.
- HAIRMAX LASERCOMB510(k)
K112524 · Decided Sep 26, 2011 · 26 days after receipt
Device type: Laser, Comb, Hair (OAP) · Physical Medicine & Rehabilitation
4 more FDA decisions with a free account
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Laser ProceduresNational determinationOn the books140.5Updated Dec 2, 2024
- Capsule Opacification Following Cataract Surgery: Discission and YAG Laser CapsulotomyLocal determinationIn effectL33946CGS Administrators, LLCUpdated Oct 30, 2026
- Panretinal (Scatter) Laser PhotocoagulationLocal determinationIn effectL33628Wellpoint FederalUpdated Jul 14, 2026
- Panretinal (Scatter) Laser PhotocoagulationLocal determinationIn effectL34064CGS Administrators, LLCUpdated Mar 27, 2026
- Laser Ablation of the ProstateLocal determinationIn effectL34090CGS Administrators, LLCUpdated Mar 25, 2026
Clinical trials
Device studies on ClinicalTrials.gov that name "Hairmax Lasercomb", any status and sponsor, newest update first.
- A Clinical Comparison of FDA-Cleared Photobiomodulation Devices for the Treatment of AlopeciaPivotal-lookingCompleted
University of MinnesotaAcademic, hospital or other
NCT06748287 · 104 participants · Start Jan 3, 2017 · Primary completion Feb 1, 2023
Device: iGrow Hair Growth System; Capillus352 and 2 more · For: Alopecia
Sites: Minneapolis, Minnesota
5 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Hairmax Lasercomb", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code OAP
37 reports: 19 malfunction, 14 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Hairmax Lasercomb"[tiab]. The summary above synthesizes these.
- The effectiveness of treatments for androgenetic alopecia: A systematic review and meta-analysis.
Adil A, Godwin M · J Am Acad Dermatol · 2017Meta-Analysis, Systematic Review
- Efficacy of fractional lasers in treating alopecia: a literature review.
Perper M, Aldahan AS, Fayne RA, et al. · Lasers Med Sci · 2017Review
- Androgenetic alopecia (male pattern hair loss) in the United States: what treatments should primary care providers recommend?
Chin EY · J Am Assoc Nurse Pract · 2013Systematic Review
- Efficacy and safety of a low-level laser device in the treatment of male and female pattern hair loss: a multicenter, randomized, sham device-controlled, double-blind study.
Jimenez JJ, Wikramanayake TC, Bergfeld W, et al. · Am J Clin Dermatol · 2014Multicenter Study, Randomized Controlled Trial
- HairMax LaserComb laser phototherapy device in the treatment of male androgenetic alopecia: A randomized, double-blind, sham device-controlled, multicentre trial.
Leavitt M, Charles G, Heyman E, et al. · Clin Drug Investig · 2009Multicenter Study, Randomized Controlled Trial
- Low-level laser therapy as a treatment for androgenetic alopecia.
Afifi L, Maranda EL, Zarei M, et al. · Lasers Surg Med · 2017Systematic Review
- Effects of the Lexington LaserComb on hair regrowth in the C3H/HeJ mouse model of alopecia areata.
Wikramanayake TC, Rodriguez R, Choudhary S, et al. · Lasers Med Sci · 2012Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
- Low-level laser treatment accelerated hair regrowth in a rat model of chemotherapy-induced alopecia (CIA).
Wikramanayake TC, Villasante AC, Mauro LM, et al. · Lasers Med Sci · 2013Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
Other devices of this type
Also filed under product code OAP.
- Hair Boom 69, Hair BoomAir, Hair Boom, Ulike Hair UpUpWontech Co., Ltd. · 510(k) 2023
- iHelmet Laser CombSlinph Technologies Co., Ltd. · 510(k) 2020
- Igrow II Hair Growth SystemApira Science, Inc. · 510(k) 2014
- Grivamax Family of Lasers, Models 272 and 148Leana Orders, Inc. · 510(k) 2021
- Hair Growth SystemXuzhou Kernel Medical Equipment Co., Ltd. · 510(k) 2020
- SuperGrow 272, Ultimate 272Super Grow Lasers · 510(k) 2018
- Hair UpY & J Bio Co., Ltd. · 510(k) 2018
- DermaScalp Laser CapDermascalp, LLC · 510(k) 2018
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.